Try it
PSM · National programmes: visceral leishmaniasis in pregnancy
Sample itemA 28-year-old woman at 14 weeks of pregnancy in a kala-azar endemic block in Bihar has fever for two months, massive splenomegaly and a positive rK39 test. Which drug is most appropriate?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. Single-dose liposomal amphotericin B 10 mg/kg intravenously
Single-dose liposomal amphotericin B (10 mg/kg) is the first-line treatment of kala-azar under the national programme and is safe in pregnancy. Miltefosine is teratogenic and contraindicated in pregnancy. Antimonials are no longer used in Bihar because of resistance and toxicity.
Option by option
A. Oral miltefosine for 28 days
Miltefosine is teratogenic and must be avoided in women of childbearing potential who are pregnant.
B. Sodium stibogluconate for 30 days
Sodium stibogluconate has been abandoned in Bihar because of resistance and toxicity.
C. Single-dose liposomal amphotericin B 10 mg/kg intravenously (correct)
Correct. Liposomal amphotericin B is first-line and can be used in pregnancy.
D. Intramuscular paromomycin for 21 days
Paromomycin is an aminoglycoside with nephrotoxic and ototoxic risk and is not first-line.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More PSM questions
- BiostatisticsOf 200 people who truly have a disease, a screening test is positive in 180. What is the…
- Environmental healthAfter one hour of contact time, what residual free chlorine level is generally recommend…
- EpidemiologyWhich study design is the most efficient for investigating risk factors of a rare disease?
- BiostatisticsIn hypothesis testing, a Type I error is: